Evidence map›Paper›PMID 26935575›Full record

ArticleMicrobial cell factories2016

Enhancing full-length antibody production by signal peptide engineering.

Yizhou Zhou, Peter Liu, Yutian Gan, Wendy Sandoval, Anand Kumar Katakam, Mike Reichelt, Linda Rangell, Dorothea Reilly

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Strategies to Enhance Periplasmic Recombinant Protein Production Yields inFrontiers in bioengineering and biotechnology · 2021
    Review
  8. EASINESS:Frontiers in immunology · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Enhancing Recombinant Protein Yields in theFrontiers in microbiology · 2019
    Article
  18. Article
  19. Secretion of recombinant proteins fromEngineering in life sciences · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Yizhou ZhouDepartment of Early Stage Cell Culture, Genentech Inc., 1 DNA way, South San Francisco, CA, 94080, USA. zyz1977627@gmail.com.
Peter LiuDepartment of Protein Chemistry, Genentech Inc., 1 DNA way, South San Francisco, CA, 94080, USA. liu.peter@gene.com.
Yutian GanDepartment of Protein Chemistry, Genentech Inc., 1 DNA way, South San Francisco, CA, 94080, USA. gan.yutian@gene.com.
Wendy SandovalDepartment of Protein Chemistry, Genentech Inc., 1 DNA way, South San Francisco, CA, 94080, USA. Sandoval.wendy@gene.com.
Anand Kumar KatakamDepartment of Pathology, Genentech Inc., 1 DNA way, South San Francisco, CA, 94080, USA. katakam.anand-kumar@gene.com.
Mike ReicheltDepartment of Pathology, Genentech Inc., 1 DNA way, South San Francisco, CA, 94080, USA. reichelt.mike@gene.com.
Linda RangellDepartment of Pathology, Genentech Inc., 1 DNA way, South San Francisco, CA, 94080, USA. rangell.linda@gene.com.
Dorothea ReillyDepartment of Early Stage Cell Culture, Genentech Inc., 1 DNA way, South San Francisco, CA, 94080, USA. reilly.dorothea@gene.com.
Genesys (United States) · USGene Therapy Laboratory · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProtein secretion to the periplasm of Escherichia coli offers an attractive route for producing heterologous proteins including antibodies. In this approach, a signal peptide is fused to the N-terminus of the heterologous protein. The signal peptide mediates translocation of the heterologous protein from the cytoplasm to the periplasm and is cleaved during the translocation process. It was previously shown that optimization of the translation initiation region (TIR) which overlaps with the nucleotide sequence of the signal sequence improves the production of heterologous proteins. Despite the progress, there is still room to improve yields using secretion as a means to produce protein complexes such as full-length monoclonal antibodies (mAbs).

resultsIn this study we identified the inefficient secretion of heavy chain as the limitation for full-length mAb accumulation in the periplasm. To improve heavy chain secretion we investigated the effects of various signal peptides at controlled TIR strengths. The signal peptide of disulfide oxidoreductase (DsbA) mediated more efficient secretion of heavy chain than the other signal peptides tested. Mutagenesis studies demonstrated that at controlled translational levels, hydrophobicity of the hydrophobic core (H-region) of the signal peptide is a critical factor for heavy chain secretion and full-length mAb accumulation in the periplasm. Increasing the hydrophobicity of a signal peptide enhanced heavy chain secretion and periplasmic levels of assembled full-length mAbs, while decreasing the hydrophobicity had the opposite effect.

conclusionsThis study demonstrates that under similar translational strengths, the hydrophobicity of the signal peptide plays an important role in heavy chain secretion. Increasing the hydrophobicity of the H-region and controlling TIR strengths can serve as an approach to improve heavy chain secretion and full-length mAb production in E. coli.

Indexed as

Protein Sorting SignalsAmino Acid SequenceAntibodiesAntibodies, MonoclonalEscherichia coliHydrophobic and Hydrophilic InteractionsImmunoglobulin Heavy ChainsInclusion BodiesMolecular Sequence DataPeptide Chain Initiation, TranslationalPeriplasmProtein EngineeringAntibodiesAntibodies, MonoclonalImmunoglobulin Heavy ChainsProtein Sorting Signals

Identifiers

PMID26935575
PMCPMC4776426
OpenAlexW2289658572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.